Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

581 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial.
Alderman EL, Levy JH, Rich JB, Nili M, Vidne B, Schaff H, Uretzky G, Pettersson G, Thiis JJ, Hantler CB, Chaitman B, Nadel A. Alderman EL, et al. Among authors: levy jh. J Thorac Cardiovasc Surg. 1998 Nov;116(5):716-30. doi: 10.1016/S0022-5223(98)00431-0. J Thorac Cardiovasc Surg. 1998. PMID: 9806378 Free article. Clinical Trial.
Platelet inhibitors and cardiac surgery.
Levy JH, Smith PK. Levy JH, et al. Ann Thorac Surg. 2000 Aug;70(2 Suppl):S1-2. doi: 10.1016/s0003-4975(00)01609-x. Ann Thorac Surg. 2000. PMID: 10966003 No abstract available.
Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial.
Verrier ED, Shernan SK, Taylor KM, Van de Werf F, Newman MF, Chen JC, Carrier M, Haverich A, Malloy KJ, Adams PX, Todaro TG, Mojcik CF, Rollins SA, Levy JH; PRIMO-CABG Investigators. Verrier ED, et al. Among authors: levy jh. JAMA. 2004 May 19;291(19):2319-27. doi: 10.1001/jama.291.19.2319. JAMA. 2004. PMID: 15150203 Clinical Trial.
Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials.
Smith PK, Shernan SK, Chen JC, Carrier M, Verrier ED, Adams PX, Todaro TG, Muhlbaier LH, Levy JH; PRIMO-CABG II Investigators. Smith PK, et al. Among authors: levy jh. J Thorac Cardiovasc Surg. 2011 Jul;142(1):89-98. doi: 10.1016/j.jtcvs.2010.08.035. Epub 2010 Sep 28. J Thorac Cardiovasc Surg. 2011. PMID: 20880552 Free article. Clinical Trial.
A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial).
Bokesch PM, Szabo G, Wojdyga R, Grocott HP, Smith PK, Mazer CD, Vetticaden S, Wheeler A, Levy JH. Bokesch PM, et al. Among authors: levy jh. J Thorac Cardiovasc Surg. 2012 May;143(5):1022-9. doi: 10.1016/j.jtcvs.2011.06.001. Epub 2011 Jul 2. J Thorac Cardiovasc Surg. 2012. PMID: 21724197 Free article. Clinical Trial.
581 results